Lung Cancer Symptom Control with Tarceva®—Approval and Labeling Information.

Approval and labeling information

Download the approved EU product label

The EU product label for Tarceva is available in all of the languages listed below. Click to download a version in the language of your choice.

To see if Tarceva has been approved in your country, see Countries with regulatory approval.

Download the product label with the new indication for pancreatic cancer.

Translated versions of the EU product label

Language	Product Label	Package Leaflet
Czech	Download PDF	Download PDF
Danish	Download PDF	Download PDF
Dutch	Download PDF	Download PDF
English	Download PDF	Download PDF
Estonian	Download PDF	Download PDF
Finnish	Download PDF	Download PDF
French	Download PDF	Download PDF
German	Download PDF	Download PDF
Greek	Download PDF	Download PDF
Hungarian (Magyar)	Download PDF	Download PDF
Italian	Download PDF	Download PDF
Latvian	Download PDF	Download PDF
Lithuanian	Download PDF	Download PDF
Polish	Download PDF	Download PDF
Portuguese	Download PDF	Download PDF
Slovak	Download PDF	Download PDF
Slovenian	Download PDF	Download PDF
Spanish	Download PDF	Download PDF
Swedish	Download PDF	Download PDF

A-D E-H I-L M-P Q-Z

Country	NSCLC approval date
Albania
Argentina	November 8, 2005
Armenia	July 14, 2005
Aruba	September 19, 2005
Australia	January 30, 2006
Austria	September 19, 2005
Azerbaijan
Bahrain	June 13, 2006
Bangladesh	October 2, 2005
Belgium	September 19, 2005
Bosnia-Herzegovina
Brazil	April 10, 2006
Bulgaria	November 1, 2005
Cambodia	February 2, 2006
Canada	July 7, 2005
Chile	July 27, 2005
China	April 6, 2006
Colombia	February 2, 2006
Costa Rica	September 13, 2005
Curacao	March 21, 2006
Cyprus	September 19, 2005
Czech Republic	September 19, 2005
Denmark	September 19, 2005
Dominican Republic	May 31, 2005
Country	NSCLC approval date
Ecuador	August 30, 2005
Egypt	March 12, 2006
El Salvador
Estonia	September 19, 2005
EU	September 19, 2005
Finland	September 19, 2005
France	September 19, 2005
Germany	September 19, 2005
Greece	September 19, 2005
Guatemala	September 16, 2005
Honduras	August 17, 2005
Hong Kong	May 3, 2006
Hungary	September 19, 2005
Country	NSCLC approval date
Iceland
India	February 27, 2006
Indonesia
Ireland	September 19, 2005
Israel	September 21, 2005
Italy	September 19, 2005
Jamaica	November 23, 2005
Kuwait	July 5, 2005
Latvia	September 19, 2005
Lithuania	September 19, 2005
Luxemburg	September 19, 2005
Country	NSCLC approval date
Macao
Macedonia
Malaysia
Malta	September 19, 2005
Mexico	June 20, 2006
Moldova
Nepal
Netherlands	September 19, 2005
New Zealand	March 23, 2006
Pakistan	March 22, 2006
Panama
Peru	May 31, 2005
Philippines	November 23, 2005
Poland	September 19, 2005
Portugal	September 19, 2005
Country	NSCLC approval date
Qatar	May 30, 2006
Romania	December 30, 2005
Russia
Serbia & Montenegro	January 26, 2006
Singapore	Febuary 10, 2006
Slovakia	September 19, 2005
Slovenia	September 19, 2005
Spain	September 19, 2005
South Korea	July 29, 2005 (100 mg) October 24, 2005 (150 mg)
Sweden	September 19, 2005
Switzerland	March 21, 2005
Taiwan	March 14, 2006
Thailand	August 1, 2005
Trinidad/Tobago	November 30, 2005
Ukraine
United Kingdom	September 19, 2005
Uruguay	February 17, 2006
US	November 18, 2004
Venezuela